trimetazidine has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altuwaijri, S; Andela, VB; Rosier, RN; Wood, J | 1 |
1 other study(ies) available for trimetazidine and Adenocarcinoma, Bronchiolo-Alveolar
Article | Year |
---|---|
Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adenosine Triphosphate; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Chromans; Coenzyme A Ligases; Fatty Acid Synthases; Fatty Acids; Gene Expression; Glucose; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Synthase; Lung Neoplasms; Mice; Neoplasms, Experimental; Oxidation-Reduction; Oxygen Consumption; PPAR gamma; Thiazolidinediones; Trimetazidine; Troglitazone | 2005 |